Article Text

other Versions

PDF
Accounting for genetic heterogeneity in homozygosity mapping: application to Mendelian susceptibility to mycobacterial disease
  1. Audrey V Grant1,2,
  2. Stéphanie Boisson-Dupuis1,2,3,
  3. Eléonore Herquelot1,2,
  4. Ludovic de Beaucoudrey1,2,
  5. Orchidée Filipe-Santos1,2,
  6. Daniel K Nolan1,2,
  7. Jacqueline Feinberg1,2,
  8. Anne Boland4,
  9. Saleh Al-Muhsen5,
  10. Ozden Sanal6,
  11. Yildiz Camcioglu7,
  12. Ayse Palanduz8,
  13. Sara Sebnem Kilic9,
  14. Jacinta Bustamante1,2,
  15. Jean-Laurent Casanova1,2,3,
  16. Laurent Abel1,2,3
  1. 1Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale, U980 Necker Medical School, Paris, France
  2. 2Paris Descartes University, Paris, France
  3. 3St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, USA
  4. 4Centre National de Génotypage, Evry, France
  5. 5Department of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
  6. 6Immunology Division, Hacettepe University Children's Hospital, Ankara, Turkey
  7. 7Department of Pediatrics, Infectious Diseases, Clinical Immunology and Allergy Division, Cerrahpaşa Medical School, Istanbul University, Istanbul, Turkey
  8. 8Department of Family Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
  9. 9Division of Pediatrics, Uludag University School of Medicine, Bursa, Turkey
  1. Correspondence to Laurent Abel, Laboratoire de Génétique Humaine des Maladies Infectieuses, Université Paris Descartes-INSERM U980, Faculté de Médecine Necker, 156 rue de Vaugirard, 75015 Paris, France; laurent.abel{at}inserm.fr
  • Genetic epidemiology
  • infectious disease
  • molecular genetics
  • immunology

Statistics from Altmetric.com

Footnotes

  • Funding The Laboratory of Human Genetics of Infectious Diseases is supported by grants from the Schlumberger Foundation, the BNP Paribas Foundation, the Institut Universitaire de France, and the European Union (grant QLK2-CT-2002-0046), the Rockefeller University Center for Clinical and Translational Science (grant 5UL1RR024143), the Rockefeller University, the Bill and Melinda Gates Foundation, the St Giles Foundation, the Jeffrey Modell Foundation and Talecris Biotherapeutics, and National Institute of Allergy and Immunology (grant 1R01AI089970). AVG was supported in part by the Fondation pour la Recherche Médicale.

  • Competing interests None.

  • Ethics approval This study was conducted with the approval of the Rockefeller University.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.